PAR1-and PAR2-induced innate immune markers are negatively regulated by PI3K/Akt signaling pathway in oral keratinocytes

被引:20
作者
Rohani, Maryam G. [1 ]
DiJulio, Dennis H. [2 ]
An, Jonathan Y. [2 ]
Hacker, Beth M. [2 ]
Dale, Beverly A. [1 ,2 ,3 ]
Chung, Whasun O. [1 ,2 ]
机构
[1] Univ Washington, Dept Med Dermatol, Seattle, WA 98195 USA
[2] Univ Washington, Dept Oral Biol, Seattle, WA 98195 USA
[3] Univ Washington, Dept Periodont, Seattle, WA 98195 USA
关键词
PROTEASE-ACTIVATED RECEPTOR-2; EPITHELIAL-CELLS; MAP KINASE; PORPHYROMONAS-GINGIVALIS; ENDOTHELIAL-CELLS; EXPRESSION; THROMBIN; INTERLEUKIN-8; SECRETION; PROTEASE-ACTIVATED-RECEPTOR-2;
D O I
10.1186/1471-2172-11-53
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Protease-Activated Receptors (PARs), members of G-protein-coupled receptors, are activated by proteolytic activity of various proteases. Activation of PAR1 and PAR2 triggers innate immune responses in human oral keratinocytes (HOKs), but the signaling pathways downstream of PAR activation in HOKs have not been clearly defined. In this study, we aimed to determine if PAR1- and PAR2-mediated signaling differs in the induction of innate immune markers CXCL3, CXCL5 and CCL20 via ERK, p38 and PI3K/Akt. Results: Our data show the induction of innate immunity by PAR1 requires both p38 and ERK MAP kinases, while PAR2 prominently signals via p38. However, inhibition of PI3K enhances expression of innate immune markers predominantly via suppressing p38 phosphorylation signaled by PAR activation. Conclusion: Our data indicate that proteases mediating PAR1 and PAR2 activation differentially signal via MAP kinase cascades. In addition, the production of chemokines induced by PAR1 and PAR2 is suppressed by PI3K/Akt, thus keeping the innate immune responses of HOK in balance. The results of our study provide a novel insight into signaling pathways involved in PAR activation.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Ischemic postconditioning exerts neuroprotective effect through negatively regulating PI3K/Akt2 signaling pathway by microRNA-124
    Miao, Wei
    Yan, Yong
    Bao, Tian-hao
    Jia, Wen-ji
    Yang, Fei
    Wang, Ying
    Zhu, Yu-hong
    Yin, Mei
    Han, Jian-hong
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 126
  • [22] CAMK1D Inhibits Glioma Through the PI3K/AKT/mTOR Signaling Pathway
    Jin, Qianxu
    Zhao, Jiahui
    Zhao, Zijun
    Zhang, Shiyang
    Sun, Zhimin
    Shi, Yunpeng
    Yan, Hongshan
    Wang, Yizheng
    Liu, Liping
    Zhao, Zongmao
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [23] The Potential Role of CERS1 in Autophagy Through PI3K/AKT Signaling Pathway in Hypophysoma
    Wang, Jingtao
    Zhang, Jimin
    Ma, Dongzhou
    Li, Xiushan
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2020, 19
  • [24] Shikonin protects chondrocytes from interleukin-1beta-induced apoptosis by regulating PI3K/Akt signaling pathway
    Wang, Leisheng
    Gai, Pengzhou
    Xu, Renguo
    Zheng, Yanpin
    Lv, Shiqiao
    Li, Yu
    Liu, Shaoxian
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (01): : 298 - 308
  • [25] PLEK2 promotes osteosarcoma tumorigenesis and metastasis by activating the PI3K/AKT signaling pathway
    Liu, Yang
    Yang, Siting
    Wang, Feng
    Zhou, Zheng
    Xu, Wenjing
    Xie, Jingjing
    Qiao, Linhui
    Gu, Yanglin
    ONCOLOGY LETTERS, 2021, 22 (01)
  • [26] TDRG1 functions in testicular seminoma are dependent on the PI3K/Akt/mTOR signaling pathway
    Wang, Yong
    Gan, Yu
    Tan, Zhengyu
    Zhou, Jun
    Kitazawa, Riko
    Jiang, Xianzhen
    Tang, Yuxin
    Yang, Jianfu
    ONCOTARGETS AND THERAPY, 2016, 9 : 409 - 420
  • [27] Effect and mechanism of PI3K/AKT/mTOR signaling pathway in the apoptosis of GC-1 cells induced by nickel nanoparticles
    Wu, Yongya
    Ma, Jun
    Sun, Yufei
    Tang, Meng
    Kong, Lu
    CHEMOSPHERE, 2020, 255
  • [28] Annexin A2 promotes development of retinal neovascularization through PI3K/ AKT signaling pathway
    Li, Chenyue
    Zhao, Zichang
    Zhao, Shihong
    CURRENT EYE RESEARCH, 2022, 47 (04) : 579 - 589
  • [29] Camptothecin inhibits the progression of NPC by regulating TGF-β-induced activation of the PI3K/AKT signaling pathway
    Li, Ben-Shan
    Huang, Ji-Yi
    Guan, Jing
    Chen, Long-Hua
    ONCOLOGY LETTERS, 2018, 16 (01) : 552 - 558
  • [30] IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways
    Duan, Shiyu
    Huang, Wenqing
    Liu, Xiaoting
    Liu, Xuming
    Chen, Nana
    Xu, Qiong
    Hu, Yukun
    Song, Wen
    Zhou, Jun
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37